Top

Published in:

Open Access 01-12-2018 | Letter to the Editor

Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder

Authors: Sarah M. Bagley, Howard Cabral, Kelley Saia, Alyssa Brown, Christine Lloyd-Travaglini, Alexander Y. Walley, Ruth Rose-Jacobs

Published in: Addiction Science & Clinical Practice | Issue 1/2018

Abstract

Background

Little is known about opioid overdose or naloxone access among pregnant women.

Objectives

The objectives of this study were to determine the prevalence of non-fatal overdose, risk factors for overdose, and naloxone access among third trimester women in treatment for opioid use disorder.

Methods

We collected baseline data from a case management parental-support intervention study. To explore the association of variables with past year overdose, we used Wilcoxon rank-sum test, Chi square or Fisher’s exact tests.

Results

Among 99 participants, 14% (95% CI 7–21%) reported past year overdose and 67% (95% CI 57–76%) had received overdose education and a naloxone kit. Younger age was the only variable associated with past year overdose.

Conclusions

In this sample, past year non-fatal overdose was common, younger age was a risk factor, and most participants had received a naloxone kit. Further work is needed to understand whether younger age is a risk factor in the general population of pregnant women with opioid use disorder and to identify other potential risk factors for overdose in this population.

Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland’s National Naloxone Programme for reducing opioid-related deaths: a before (2006–10) versus after (2011–13) comparison. Addiction. 2016;111(5):883–91. https://doi.org/10.1111/add.13265.CrossRefPubMedPubMedCentral

Department of Health and Human Services. (2015). Opioid abuse in the U.S. and HHS actions to address opioid-drug related overdoses and deaths.

Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002. https://doi.org/10.1097/AOG.0000000000000208.CrossRefPubMedPubMedCentral

Edvardsson K, Ivarsson A, Eurenius E, Garvare R, Nyström ME, Small R, Mogren I. Giving offspring a healthy start: parents’ experiences of health promotion and lifestyle change during pregnancy and early parenthood. BMC Public Health. 2011;11(1):936. https://doi.org/10.1186/1471-2458-11-936.CrossRefPubMedPubMedCentral

Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. Morb Mortal Wkly Rep. 2018;67(31):845.CrossRef

Mack KA, Jones CM, Paulozzi LJ. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999–2010. MMWR. 2013;62(26):537–42.

McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, et al. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013;45(1):38–43. https://doi.org/10.1016/j.jsat2012.12.007.CrossRefPubMedPubMedCentral

Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):650–5. https://doi.org/10.1038/jp.2015.36.CrossRefPubMedPubMedCentral

Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018;132(2):466–74. https://doi.org/10.1097/AOG.0000000000002734.CrossRefPubMed

10.

Vonderheid SC, Norr KF, Handler AS. Prenatal health promotion content and health behaviors. West J Nurs Res. 2007;29(3):258–76. https://doi.org/10.1177/0193945906296568.CrossRefPubMed

11.

Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44(2):241–7. https://doi.org/10.1016/j.jsat.2012.07.004.CrossRefPubMed

12.

Walley AY, Xuan Z, Hackman H, Quinn E, Doe-Simkins M, Sorenson-Alawad A, Ruiz S. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. https://doi.org/10.1136/bmj.f174.CrossRefPubMedPubMedCentral

Title: Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder
Authors: Sarah M. Bagley
Howard Cabral
Kelley Saia
Alyssa Brown
Christine Lloyd-Travaglini
Alexander Y. Walley
Ruth Rose-Jacobs
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Addiction Science & Clinical Practice / Issue 1/2018
Electronic ISSN: 1940-0640
DOI: https://doi.org/10.1186/s13722-018-0126-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder

Abstract

Background

Objectives

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Standardised alcohol screening in primary health care services targeting Aboriginal and Torres Strait Islander peoples in Australia

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting

Emergency department screening and interventions for substance use disorders

Substance use patterns and in-hospital care of adolescents and young adults attending music concerts

Substance use and the HIV care continuum: important advances

The SUMMIT ambulatory-ICU primary care model for medically and socially complex patients in an urban federally qualified health center: study design and rationale